secwatch.observer — SEC 8-K summary
======================================

Issuer:     Telomir Pharmaceuticals, Inc. (TELO)
CIK:        0001971532
Form:       8-K
Filed at:   2026-09-16T20:30:23+00:00
Accession:  0001493152-26-042926
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Telomir shareholders elect four directors, ratify auditor at 2026 annual meeting
--------------------------------------------------------------------------------

- 47,129,480 shares voted (68.53% of 68,774,954 outstanding) at Sept 11, 2026 meeting.
- Directors elected: Erez Aminov, Matthew Whalen, Edward MacPherson, Matthew Del Giudice, M.D.; votes for ranged from 41.2M to 43.4M.
- Ratification of Salberg & Company, P.A. as independent auditor passed with 46,998,583 votes for, 69,548 against.
- Adjournment proposal approved: 44,841,042 for, 2,271,263 against, 17,175 abstained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1971532/000149315226042926/0001493152-26-042926-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1971532/000149315226042926/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-042926

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer